Increase cases of thyroid disorders, surge in prevalence of lifestyle diseases,increase in consumption of alcohol & tobacco are key factors impacting the market

WILMINGTON, DELAWARE, UNITED STATES, October 30, 2023 /EINPresswire.com/ -- The Thyroid Function Test Market was valued at US$ 1.5 Bn in 2021. A 5.4% CAGR is expected from 2022 to 2031, and by 2031, the market is expected to gain US$ 2.6 Bn.

A thyroid function test, also known as a thyroid test, assesses the levels of hormones produced by both the thyroid gland and the pituitary gland in the brain. It's important to note that the accuracy of thyroid test results may be influenced by medications, including vitamin supplements and herbal remedies. Therefore, it is crucial to undergo these tests under the guidance and recommendation of a medical professional.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=35750

Alcohol consumption is recognized as a significant risk factor for disease and disability. On a global scale, high-income countries in developed regions have the highest rates of alcohol consumption, with approximately 50.1% of the adult population in the United States regularly consuming alcohol. Numerous studies have highlighted a negative correlation between alcoholism and the hypothalamic-pituitary-thyroid (HPT) axis.

Regular alcohol intake suppresses the production of peripheral thyroid hormones, resulting in the release of T3 and T4, while also reducing the activity of type II 5’-deiodinase, thereby impacting metabolic function. This can ultimately lead to the development of hypothyroidism. Furthermore, tobacco use can also bring about alterations in thyroid function tests, such as decreased TSH levels and increased levels of thyroid hormones.

Key Developments in the Thyroid Function Test Market

• Roche introduced the Elecsys Thyroid Function Test, a high-performance immunoassay that measures thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), and free thyroxine (FT4) levels. This assay offers enhanced sensitivity and precision.
• Abbott launched the ARCHITECT Free Thyroxine (FT4) assay, designed for use on the ARCHITECT family of analyzers. The assay provides accurate measurements of FT4 levels, aiding in the diagnosis and management of thyroid disorders.

𝐃𝐨 𝐲𝐨𝐮 𝐡𝐚𝐯𝐞 𝐚𝐧𝐲 𝐪𝐮𝐞𝐫𝐲 𝐫𝐞𝐠𝐚𝐫𝐝𝐢𝐧𝐠 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡? 𝐀𝐬𝐤 𝐲𝐨𝐮𝐫 𝐐𝐮𝐞𝐫𝐲: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=35750

• Siemens Healthineers developed the ADVIA Centaur XP Thyroid Fun
ction Test, which measures TSH, FT3, and FT4 levels. This test offers improved accuracy and shorter turnaround times in clinical laboratories.
• Bio-Rad Laboratories expanded its thyroid function test offerings with the introduction of the BioPlex 2200 Free T3 and Free T4 assays. These assays provide clinicians with accurate measurements of FT3 and FT4 levels.

In the forecast period, the diagnostic laboratories sector is expected to hold a substantial portion of the market share. This projection is attributed to the growing adoption of advanced technologies within these facilities. According to a recent study, TFT algorithms could be integrated into diagnostic laboratories with no compromise in therapeutic precision. Such integration has the potential to reduce direct costs and, simultaneously, safeguard patients from the repercussions of low-value healthcare practices.

Key Players in Thyroid Function Test Market

• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd
• Abbott Laboratories
• DiaSorin S.p.A.
• Danaher Corporation
• Siemens Healthineers
• Merck KGaA
• bioMérieux SA
• Qualigen Inc.
• Autobio Diagnostics Co., Ltd.

Market Segmentation

Type
• TSH Test
• T4 Test
• T3 Test
• Others

𝐇𝐚𝐯𝐞 𝐀𝐧𝐲 𝐐𝐮𝐞𝐫𝐲? 𝐀𝐬𝐤 𝐎𝐮𝐫 𝐄𝐱𝐩𝐞𝐫𝐭𝐬: https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=35750

End-user

• Hospital-based Laboratories
• Diagnostic Laboratories
• Research Institutes
• Others

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 –

Global Clinical Laboratory Services Market is Anticipated to Hold a Value worth US$ 12.8 Bn by 2030

Demand for Cardiovascular Diagnostic & Monitoring Devices Market Size,Trends,Analysis,Scope,Growth Drivers

Nikhil Sawlani
Transparency Market Research Inc.
+ +1 518-618-1030
email us here
Visit us on social media:
Twitter
LinkedIn
YouTube

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.